Maxim Group Maintains Buy on Bionomics, Raises Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
Maxim Group analyst Jason McCarthy maintains a 'Buy' rating on Bionomics (NASDAQ:BNOX) and raises the price target from $7 to $10.
September 28, 2023 | 4:43 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Maxim Group maintains a 'Buy' rating on Bionomics and raises the price target from $7 to $10.
The raised price target by Maxim Group indicates a positive outlook for Bionomics. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100